How much is Wegovy on TrumpRx?

Wegovy starts at $149 monthly for the 1.5 mg pill or $199 for two eligible introductory pen fills, as checked September 10, 2026. Ongoing pen strengths through 2.4 mg cost $349; the 7.2 mg pen costs $399. The 4 mg pill costs $199, and 9 or 25 mg costs $299. Eligibility and offer terms apply.

Are Mounjaro and Foundayo listed on TrumpRx?

Both are listed as of September 10, 2026. Mounjaro pens are $499 monthly across the listed strengths. Foundayo tablets start at $149, with higher prices depending on strength and refill eligibility. Both listings direct people to LillyDirect. Foundayo contains orforglipron, a different medicine from the tirzepatide in Mounjaro, so these are separate prescribing decisions.

Can insurance pay for a TrumpRx cash offer?

The cash offer operates outside insurance. The Novo terms say patients cannot seek insurance reimbursement or count the purchase toward their insurance spending limits. A covered prescription may have a lower copay than the cash price. The comparison needs the actual plan benefit and the exact product offer, since terms differ across medicines.

Can someone with Medicare use TrumpRx?

Medicare enrollment is not an automatic exclusion from every cash offer, but the exact terms matter. The Novo pen pages permit payment outside insurance; the pill pages contain conflicting wording that needs pharmacy confirmation. Separately, eligible beneficiaries may receive certain medicines through the Medicare GLP-1 Bridge for $50 monthly. That coverage program is different from a TrumpRx coupon.

Is a compounded prescription the same as a TrumpRx medicine?

They are different finished products. TrumpRx lists manufacturer brands, while compounded semaglutide or tirzepatide is prepared by a pharmacy for an individual prescription. A shared active ingredient does not establish that the preparations are interchangeable. Comparing costs also means checking whether the medical visit, supplies, delivery and follow-up are included in each quote.

TrumpRx GLP-1 Prices: Beyond the Starting Price

TrumpRx GLP-1 prices start at $149 for the Wegovy pill, $199 for eligible introductory Wegovy and Ozempic pen fills, and $299 for Zepbound vials. Those are starting prices, not a flat bill for every prescription. GLP-1 medicines act on a hormone signal involved in appetite and blood sugar; the price depends on the medicine, strength and offer terms.

As of September 10, 2026, the day this article was written, TrumpRx's live listings show those offers, with higher prices for later fills or other strengths. The useful number is what the prescribed medicine will cost after the introductory offer ends.

TrumpRx GLP-1 prices by medicine

The table reflects the live product pages and their manufacturer terms checked on the writing day. Strength means the amount of medicine in a dose. These amounts identify price tiers; the prescriber sets the actual dose.

Listed medicine	Monthly cash price	What changes the bill
Wegovy pen, semaglutide	$199 for two eligible starting fills; then $349	The introductory offer covers 0.25 and 0.5 mg. Ongoing strengths through 2.4 mg cost $349; the 7.2 mg pen costs $399.
Ozempic pen, semaglutide	$199 for two eligible starting fills; then $349 or $499	After the offer, 0.25, 0.5 and 1 mg cost $349; 2 mg costs $499.
Wegovy pill, semaglutide	Starts at $149	NovoCare lists $149 for 1.5 mg, $199 for 4 mg and $299 for 9 or 25 mg, per 30 tablets.
Zepbound vial, tirzepatide	$299 at 2.5 mg; $399 at 5 mg; $449 at higher strengths under the offer	Higher-strength refills have a 45-day purchase window. A month is 28 days.
Mounjaro pen, tirzepatide	$499	Lilly lists this cash price across the six pen strengths.
Foundayo tablets, orforglipron	$149 at 0.8 or 2.5 mg; $199 at 5.5 mg; $299 at 9 mg and eligible 14.5 or 17.2 mg strengths	The two discounted middle strengths have an end date; the highest strengths have refill conditions.

The NovoCare offer confirms the Wegovy pill tiers. Lilly's Mounjaro page confirms its flat strength pricing. TrumpRx also lists an Ozempic pill starting at $149 per 30 tablets, with prices varying by strength.

For someone comparing these semaglutide offers with a compounded prescription, the distinction starts with the product: a pharmacy-prepared formulation is a separate medicine from the branded pen or tablet.

What the November agreement changed

The government's pricing agreements with Lilly and Novo Nordisk were announced on November 6, 2025. The White House fact sheet described lower consumer cash prices and separate government-program prices. Its $245 Medicare figure was not a universal pharmacy cash offer.

Lilly's announcement described a direct pharmacy route and dose-based prices. Novo Nordisk's announcement described lower semaglutide prices and broader access, while noting that agreement details still needed finalizing. Today's product terms supply the specifics that those announcements could not.

What it means for someone paying for a prescription

TrumpRx connects people with cash offers. For the Novo products above, its pages provide a coupon for a dispensing pharmacy. For the Lilly products, they direct people to LillyDirect for eligibility checks and pharmacy fulfillment. A listing does not itself provide a prescription or a medical visit.

The route can help someone whose insurance leaves them with a larger bill, including someone without drug coverage. Someone with a lower copay—their share of an insured prescription—may pay less through their plan. The Novo cash terms prohibit claiming reimbursement or counting that spending toward insurance spending limits.

Medicare needs a separate comparison. As of September 10, 2026, the day this article was written, the Medicare GLP-1 Bridge launched July 1, 2026 offers certain medicines to eligible beneficiaries for $50 monthly. The Medicare GLP-1 coverage guide explains that program.

Cash-offer eligibility also varies. The TrumpRx Wegovy pill page contains conflicting government-insurance wording; NovoCare explicitly permits government-insured patients to self-pay outside coverage. The dispensing pharmacy needs to confirm which terms apply.

For tirzepatide, the separate LillyDirect versus compounded tirzepatide comparison explains the dispensing routes. TrumpRx's referral does not change which formulation the prescription names.

What a lower brand price does not mean

A discount does not make a brand product and a compounded preparation the same medicine. The U.S. Food and Drug Administration (FDA) reviews finished drug products. Through Promise, semaglutide and tirzepatide are dispensed as compounded medications, prepared by a pharmacy for an individual prescription, which are different from an FDA-approved product: the formulations offered here are not FDA-approved.

As checked September 10, 2026, FDA's compounding questions and answers explain that these preparations do not undergo the agency's review for safety, effectiveness or quality before marketing. A licensed provider may still prescribe a compounded formulation when medically appropriate and consistent with applicable requirements; that decision is between the patient and the doctor.

The comparison is therefore about the finished medicine and the care around it: what is dispensed, who reviews the prescription, and whether visits, supplies, delivery and follow-up are included or billed separately. A medication price alone cannot answer all of that.

Why later refills deserve attention

The reason to look beyond month one is medical as well as financial. In STEP 4, a semaglutide trial published in JAMA in 2021, 803 adults continued treatment or changed to placebo—an injection without active medicine—after 20 weeks. Over the next 48 weeks, average weight fell another 7.9% with continued treatment and rose 6.9% after the switch.

In SURMOUNT-4, published in JAMA in 2024, 670 adults who completed 36 weeks of tirzepatide continued it or switched to placebo. Over the next 52 weeks, weight rose 14.0% in the switch group and fell another 5.5% with continued treatment.

These trials support discussing ongoing affordability with the prescriber. They do not predict an individual's outcome, test TrumpRx, or establish the results of a compounded formulation. That distinction matters just as much when comparing semaglutide prices.

What to watch next

The current Wegovy and Ozempic pen introductory terms end December 31, 2026. Foundayo's terms also put that date on its 2.5 and 5.5 mg discounts. Its highest strengths cost $349 without the $299 offer; continued eligibility requires a refill purchase within 45 days of receipt.

Zepbound's terms use the same 45-day window for higher-strength refills. Outside it, 7.5 mg costs $499 and 10–15 mg costs $699. These are price conditions, not reasons to change a prescribed schedule.

At Promise, a licensed provider reviews every request and not everyone qualifies. The useful next conversation covers both medical suitability and a budget that extends beyond the first fill.